Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!

BioAnalyte announced today that long-time lead developer Vladimir Georgiev has assumed production management responsibilities for the company's Regatta™ biomarker discovery product line.

"Vladimir's leadership and clarity of vision have contributed to the disciplined development of Regatta core components as well as overall platform design," said Peter Leopold. "We are confident that he will bring similar precision to engineering a distribution solution that will enable our product and sales strategies."

ProteinTrawler™, the first component of Regatta, is in final stages of testing and preparation for widespread web distribution. ProteinTrawler reduces gigabyte liquid chromatography mass spectrometry (LCMS) datasets to manageable lists of key features used in biomarker discovery. Georgiev, who is the principal architect of ProteinTrawler, will manage a staff of four developers and designers working in such diverse areas as algorithm design, graphical interface development, release management, license enforcement and web-based license distribution.

"Our biggest technical challenge is proNets™ license distribution," Georgiev said. "Our design and implementation emphasize ease of use and reliability. When our customers buy and use dataset-dependent licenses over the web, we will have revolutionized the sales model for capital software."

Georgiev, a 2002 graduate of the University of Southern Maine computer science department, joined BioAnalyte in January 2003. In addition to ProteinTrawler, he designed and developed BioAnalyte Ganglion+™, an embedded biomarker discovery package developed under a US Defense Department subcontract, as well as BioAnalyte SpyGlass™, a custom data visualization tool. Previously, Georgiev was a network specialist for Downtime Inc. of Brunswick, ME. Georgiev resides in Portland.

About BioAnalyte

Founded in Portland in 2001, BioAnalyte (bioanalyte.com) is a Portland-based biomarker discovery partner company. It develops cross-platform software tools to facilitate high-speed interpretation of the torrent of proteomics and genomic data made possible by contemporary instrumentation. BioAnalyte's ProteinTrawler™ and PeptideTrawler™ were developed in collaboration with the Food and Drug Administration's Center for Food Safety and Applied Nutrition. BioAnalyte ProteinTrawler™ helped the FDA discover a protein biomarker for a deadly food-borne bacterium similar to the one that causes cholera.

Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BioAnalyte, Inc. securities in any jurisdiction including any other companies listed or named in this release.